Abstract
The Myc/Max/Mad network of transcriptional regulatory proteins plays an essential role in cell proliferation, growth, apoptosis, and differentiation. Whereas Myc proteins affect cell cycle progression positively, Mad proteins are negative regulators of cell proliferation. It has been shown in several in vitro systems that Mad proteins antagonize c-Myc functions. In this report we describe the inhibition of tumor cell outgrowth in vivo by Mad1 expression. Transformed cell lines were generated by co-transfection of c-myc, c-H-ras, and a chimeric mad1ER construct into primary rat embryo cells (MRMad1ER cells). Activation of Mad1 by 4-Hydroxy-Tamoxifen (OHT) resulted in abrogation of telomerase activity, reduced cloning efficiency, and decreased proportion of cells in S phase. Injection of MRMad1ER cells into syngenic rats induced aggressively growing tumors after a short latency period. This tumor growth was inhibited by OHT-treatment of animals, with the extent of inhibition correlating with the amount of OHT injected. No effect of OHT on tumor growth was observed with similarly transformed Myc/Ras cell lines which did not express Mad1ER. These data demonstrate that Mad1 is able to suppress Myc/Ras-mediated transformation under in vivo conditions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, DePinho R . 1997 Nature 387: 49–55
Amati B, Frank SR, Donjerkovic D, Taubert S . 2001 Biochim. Biophys. Acta 1471: M135–M145
Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW . 1996 Cancer Res. 156: 645–650
Ayer DE, Eisenman RN . 1993 Genes Dev. 7: 2110–2119
Ayer DE, Kretzner L, Eisenman RN . 1993 Cell 72: 211–222
Bazarov AV, Adachi S, Li S-F, Mateyak MK, Wie S, Sedivy JM . 2001 Cancer Res. 61: 1178–1180
Bejarano MT, Albihn AA, Cornvik T, Brijker SO, Asker C, Osorio LM, Henriksson M . 2000 Exp. Cell Res. 260: 61–72
Blackwood E, Eisenman R . 1991 Science 252: 1211–1217
Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW . 1997 Cell 91: 25–34
Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Lüscher B . 2001 Genes Dev. 15: 2042–2047
Cerni C, Bousset K, Seelos C, Burkhard H, Henriksson M, Lüscher B . 1995 Oncogene 11: 587–596
Cerni C, Patocka K, Meneguzzi G . 1990 Virology 177: 427–436
Cerni C . 2000 Mut. Res. 462: 31–47
Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD . 1995 Nature Med. 1: 638–643
Cole MD, McMahon SB . 1999 Oncogene 18: 2916–2924
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR . 2000 Proc. Natl. Acad. Sci. USA 97: 3260–3265
Cong Y-S, Bacchetti S . 2000 J. Biol. Chem. 275: 35665–35668
Cultraro CM, Bino T, Segal S . 1997 Mol. Cell. Biol. 17: 2353–2359
DePinho RA, Schreiber-Agus N, Alt FW . 1991 Adv. Cancer Res. 57: 1–46
Eilers M . 1999 Mol. Cells 9: 1–6
Facchini LM, Penn LZ . 1998 FASEB J. 12: 2149–2154
Falcetti ML, Falcone G, D'Ambrosio E, Verna R, Alema S, Levi A . 1999 Oncogene 18: 1515–1519
Foley KP, McArthur GA, Quéva C, Hurlin PJ, Soriano P, Eisenman RN . 1998 EMBO J. 17: 774–785
Gehring S, Rottmann S, Menkel AR, Mertsching J, Krippner-Heidenreich A, Lüscher B . 2000 J. Biol. Chem. 275: 10413–10420
Good DJ, Polverini PJ, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, Bouck NP . 1990 Proc. Natl. Acad. Sci. USA 87: 6624–6628
Gorman C, Padmanabhan R, Howard BH . 1983 Science 221: 551–553
Grandori C, Cowley SM, James LP, Eisenman RN . 2000 Annu. Rev. Cell. Dev. Biol. 16: 653–699
Greenberg RA, O'Hagan RC, Deng H, Yiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA . 1999 Oncogene 18: 1219–1226
Gundimeda U, Chen ZH, Gopalakrishna R . 1996 J. Biol. Chem. 23: 13504–13514
Günes C, Lichtsteiner S, Vasserot AP, Englert C . 2000 Cancer Res. 60: 2116–2121
Guo QM, Malek RL, Kim S, Chiao C, He M, Ruffy M, Sanka K, Lee NH, Dang CV, Liu ET . 2001 Cancer Res. 60: 5922–5928
Han S, Park K, Kim H-Y, Lee M-S, Kim Y-D, Yuh YJ, Kim SR, Suh HS . 2000 Cancer 88: 1623–1632
Hassig C, Fleischer T, Billin AN, Schreiber SL, Ayer DE . 1997 Cell 89: 341–347
Heinzel T, Lavinsky RM, Muller T-M, Söderström M, Laherty CD, Torchia J, Yang W-M, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG . 1997 Nature 387: 43–48
Henriksson M, Lüscher B . 1996 Adv. Cancer Res. 68: 109–182
Hurlin PJ, Quéva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN . 1995 EMBO J. 14: 5646–5659
Hurlin P, Quéva C, Eisenman RN . 1997 Genes Dev. 11: 44–58
Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN . 1999 EMBO J. 18: 7019–7028
Johnson LA, Prober DA, Edgar BA, Eisenman RN, Gallant P . 1999 Cell 98: 779–790
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Wienrich SL, Shay JW . 1994 Science 266: 2011–2015
Koskinen PJ, Ayer DE, Eisenman RN . 1995 Cell Growth Differ. 6: 623–629
Laherty CD, Yang W-M, Sun J-M, Davie JR, Seto E, Eisenman RN . 1997 Cell 89: 349–356
Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA . 1994 Proc. Natl. Acad. Sci. USA 91: 5503–5507
Land H, Parada LF, Weinberg RA . 1983 Nature 304: 596–602
Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL . 1996 Cancer Res. 56: 5391–5396
Larsson LG, Pettersson M, Oberg F, Nilsson K, Lüscher B . 1994 Oncogene 9: 1247–1252
Lee TH, Chuang LY, Hung WC . 2000 Oncogene 19: 3766–3773
Lüscher B . 2001 Gene 277: 1–14
Lüscher B, Larsson L-G . 1999 Oncogene 8: 2954–2965
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD . 1998 Cell 94: 363–374
McMahon SB, Wood MA, Cole MD . 2000 Mol. Cell. Biol. 20: 556–562
Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Nigro CL, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R . 1997 EMBO J. 16: 2892–2906
Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, Thomas-Tikhonenko A . 2000 Cell Growth Differ. 11: 201–210
Oh S, Song Y-H, Yim J, Kim TK . 2000 Oncogene 19: 1485–1490
O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelmann JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P, DePinho RA . 2000 Nature Genet. 24: 113–119
Prasad GL, Masuelli L, Raj MH, Harindranath N . 1999 Oncogene 18: 2027–2031
Pulverer B, Sommer A, McArthur GA, Eisenman RN, Luscher B . 2000 J. Cell Physiol. 183: 399–410
Quéva C, Hurlin PJ, Foley KP, Eisenmann RN . 1998 Oncogene 16: 967–977
Quéva C, McArthur GA, Ramos LS, Eisenman RN . 1999 Cell Growth Differ. 10: 785–796
Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS . 1995 Cancer Res. 55: 4575–4580
Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN, Ayer DE . 1996 Mol. Cell. Biol. 16: 2796–2801
Roy B, Reisman D . 1995 Cell Biol. Intern. 19: 307–313
Shay JW, Bacchetti S . 1997 Eur. J. Cancer 33: 787–791
Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Lüscher B . 1997 Curr. Biol. 7: 357–365
Treon SP, Teoh G, Urashima M, Ogata A, Chauhan D, Webb IJ, Anderson KC . 1998 Blood 92: 1749–1757
Ulaner GA, Hu J-F, Vu TH, Giudice LC, Hoffman AR . 1998 Cancer Res. 58: 4168–4172
Västrik I, Kaipainen A, Penttilä T-L, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K . 1995 J. Cell. Biol. 128: 1197–1208
Wang J, Xie LY, Allan S, Beach D, Hannon GJ . 1998 Genes Dev. 12: 1769–1774
Wu K-J, Grandori C, Amacker M, Simon-Vermont N, Polack A, Lingner J, Dalla-Favera R . 1999 Nature Gen. 21: 220–224
Xu D, Popov N, Hou M, Wang Q, Björkholm M, Gruber A, Menkel AR, Henriksson M . 2001 Proc. Natl. Acad. Sci. USA 98: 3826–3831
Zervos A, Gyuris J, Brent R . 1993 Cell 72: 223–232
Zhu J, Wang H, Bishop M, Blackburn EH . 1999 Proc. Natl. Acad. Sci. USA 96: 3723–3728
Acknowledgements
We thank G Krupitza for critical reading of the manuscript, D Ayer, RN Eisenman, L Kretzner, and J Lüscher-Firzlaff for plasmids, M Sjöberg for the ER antibody, and K Andersson, M Hajek, and C Schreiner for excellent technical assistance. This work was supported by the Institute of Cancer Research of the University of Vienna (CC), the Deutsche Forschungsgemeinschaft (BL), and the Swedish Cancer Society (MH).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cerni, C., Skrzypek, B., Popov, N. et al. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1. Oncogene 21, 447–459 (2002). https://doi.org/10.1038/sj.onc.1205107
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205107
Keywords
This article is cited by
-
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Journal of Hematology & Oncology (2021)
-
In silico whole-genome scanning of cancer-associated nonsynonymous SNPs and molecular characterization of a dynein light chain tumour variant
Oncogene (2005)
-
Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras
Oncogene (2003)